Scientific Learning Reports Record First Quarter Results

* Reuters is not responsible for the content in this press release.

Thu Apr 22, 2010 4:00pm EDT

http://www.businesswire.com/news/home/20100422006837/en

Booked Sales Increase 33% and Net Loss per Share Improves 38% to $0.10 from
$0.16 
OAKLAND, Calif.--(Business Wire)--
Scientific Learning Corporation (NASDAQ:SCIL), a leading provider of
technologies for accelerated learning, today announced financial results for the
first quarter ended March 31, 2010. 

First Quarter Summary (1Q10 vs. 1Q09)

* Total revenues increased 28% to a first quarter record of $11.1 million, total
booked sales increased 33% to a first quarter record of $8.0 million and K-12
booked sales increased 33% to a first quarter record of $7.3 million; 
* Gross profit increased 35% to $8.1 million and gross margin increased to 73.3%
of total revenues from 69.9% of total revenues; 
* Operating loss improved to $1.9 million from an operating loss of $2.9
million; 
* Net loss per share improved 38% to $0.10 from $0.16; and 
* Cash and short-term investments increased to $16.3 million from $6.0 million

Andy Myers, Chief Executive Officer stated, "We delivered strong financial
results in what is typically our seasonally slowest period of the year. Sales
momentum in the first quarter was driven by our ability to leverage increased
funding levels in Title I and IDEA programs through operational changes and a
differentiated product offering. We continue to invest in the technology and
infrastructure necessary to strengthen our product development and remain
optimistic in our long-term ability to continue to grow our business." 

Operating Results

Total revenues increased 28% to $11.1 million in the first quarter of 2010
compared to $8.6 million in the first quarter of 2009. Product revenues
increased 39% to $5.5 million and service and support revenue increased 20% to
$5.6 million. Total and K-12 booked sales both increased 33% in the first
quarter. 

Gross profit increased 35% to $8.1 million in the first quarter of 2010 compared
to $6.0 million in the first quarter of 2009. Gross profit margin increased 340
basis points to 73.3% of total revenues. The increase in the gross margin was
driven by a revenue mix shift toward higher-margin product sales and increases
in both product and service and support gross margins. Product gross margin
increased to 90.6% from 89.9%, while service and support gross margin increased
to 56.3% from 52.8%. 

Total operating expenses increased 12% to $10.0 million in the first quarter of
2010 compared to $8.9 million in the first quarter of 2009. Sales and marketing
expenses increased 9% to $6.0 million, research and development expenses
increased 28% to $2.0 million and general and administrative expenses increased
6% to $2.1 million. The year-over-year increase in research and development
expenses was impacted by the capitalization of approximately $300,000 of
software development costs in the first quarter of 2009. If these costs had been
expensed instead of capitalized, research and development expenses would have
increased 6% in the first quarter 2010. 

Earnings before interest, taxes, depreciation, amortization, and stock
compensation (EBITDAS) in the first quarter improved to negative $800,000 from
negative $2.1 million. Operating loss improved to $1.9 million in the first
quarter 2010 compared to $2.9 million in the first quarter 2009. Net loss
improved to $1.9 million, or $0.10 per share, in the first quarter of 2010
compared to a net loss of $2.9 million, or $0.16 per share, in the first quarter
of 2009. 

The company believes that booked sales and EBITDAS (both non-GAAP measures) are
important measures of operating performance and has chosen to disclose these
figures as part of the earnings results. EBITDAS and booked sales should not be
considered in isolation from net income and revenue and are not intended to
represent substitute measures of performance calculated under GAAP.
Reconciliations of booked sales, revenue and deferred revenue, and EBITDAS and
net income (net loss) are included at the end of this earnings release and in
the investor information section of our website, www.scientificlearning.com. 

Selected Balance Sheet Information

As of March 31, 2010, cash and short term investments were $16.3 million
compared to $20.7 million at December 31, 2009 and $6.0 million at March 31,
2009. The sequential quarterly decline is driven by normal seasonal trends in
the business. Net accounts receivable were $3.4 million at March 31, 2010
compared to $6.4 million at December 31, 2009 and $5.4 million at March 31,
2009. As of March 31, 2010 and December 31, 2009 there were no short-term
borrowings under our line of credit. As of March 31, 2009, short term borrowings
were $2.5 million. 

Conference Call Information

A conference call to discuss first quarter results and the outlook for 2010 is
scheduled for today, April 22, 2009 at 5:00 p.m. Eastern Time / 2:00 p.m.
Pacific Time. Investors and analysts interested in participating in the call are
invited to dial (866) 652-3154 (domestic) or (706) 634-7311 (international),
conference id number 64742562 approximately 10 minutes prior to the start of the
call. The conference call will be available live on the Investor Information
portion of the Company`s website at http://www.scilearn.com/investorinfo. A
replay of this teleconference will be made available on the Scientific Learning
website approximately two hours following the conclusion of the call. To hear
the replay by phone, please call (800) 642-1687 (domestic) and (706) 645-9291
international and enter conference id number 64742562. 

About Scientific Learning Corporation

Scientific Learning creates educational software that accelerates learning by
improving the processing efficiency of the brain. Based on more than 30 years of
neuroscience and cognitive research, the Fast ForWord family of products
provides struggling readers with computer-delivered exercises that build the
cognitive skills required to read and learn effectively. Scientific Learning's
Reading AssistantTM 
      combines advanced speech recognition technology with scientifically-based
courseware to help students strengthen fluency, vocabulary and comprehension to
become proficient, life-long readers. The efficacy of the products has been
established by more than 550 research studies and publications. For more
information, visit www.scientificlearning.com or call toll-free 888-452-7323. 

Forward-Looking Statements

This press release contains forward-looking statements that are subject to the
safe harbor created by the federal securities laws. Such statements include,
among others, statements relating to the Company`s investment in technology and
infrastructure, product development efforts and long-term growth. Such
statements are subject to substantial risks and uncertainties. Actual events or
results may differ materially as a result of many factors, including but not
limited to: general economic and financial conditions (including current adverse
conditions in the general economy and in the financial and credit markets);
availability of funding to purchase the Company's products and generally
available to schools including the amount and duration of federal stimulus
funding; unexpected challenges in product development; the acceptance of new
products and product changes; seasonality and sales cycles in Scientific
Learning's markets; competition; factors affecting trends in education; the
extent to which the Company's marketing, sales and implementation strategies are
successful; personnel changes; the Company's ability to continue to demonstrate
the efficacy of its products, and other risks detailed in the Company's SEC
reports, including but not limited to the Report on Form 10-K for the year ended
December 31, 2009 (Part I, Item 1A, Risk Factors), filed March 3, 2010. The
Company disclaims any obligation to update information contained in these
forward-looking statements, whether as a result of new information, future
events, or otherwise.

 SCIENTIFIC LEARNING CORPORATION                                                                                                 
 CONDENSED BALANCE SHEETS                                                                                                        
 (In thousands)                                                                                                                  
 Unaudited                                                                                                                       
                                                                                                                           
                                                March 31,                December 31,               March 31,              
                                                      2010                    2009                    2009           
 Assets                                                                                                                    
 Current assets:                                                                                                           
 Cash and cash equivalents                      $     8,281            $      20,679            $     5,981          
 Short-term investments                               7,997                   -                       -              
 Accounts receivable, net                             3,418                   6,390                   5,441          
 Prepaid expenses and other current assets            2,322                   2,142                   1,797          
                                                                                                                           
 Total current assets                                 22,018                  29,211                  13,219         
                                                                                                                           
 Property and equipment, net                          2,143                   1,780                   1,724          
 Goodwill                                             4,568                   4,568                   4,568          
 Other intangible assets, net                         5,215                   5,476                   6,190          
 Other assets                                         2,138                   2,093                   1,365          
                                                                                                                           
 Total assets                                   $     36,082           $      43,128            $     27,066         
                                                                                                                           
                                                                                                                           
 Liabilities and stockholders' equity                                                                                      
 Current liabilities:                                                                                                      
 Accounts payable                               $     457              $      812               $     725            
 Accrued liabilities                                  3,629                   7,362                   3,062          
 Borrowings under line of credit                      -                       -                       2,500          
 Deferred revenue                                     14,345                  15,859                  12,946         
                                                                                                                           
 Total current liabilities                            18,431                  24,033                  19,233         
 Deferred revenue, long-term                          6,177                   6,371                   4,327          
 Other liabilities                                    845                     795                     656            
                                                                                                                           
 Total liabilities                                    25,453                  31,199                  24,216         
                                                                                                                           
                                                                                                                           
 Stockholders' equity:                                                                                                     
 Common stock and additional paid in capital          87,790                  87,182                  85,764         
 Accumulated deficit                                  (77,152  )              (75,253  )              (82,914  )     
 Accumulated other comprehensive loss                 (9       )              -                       -              
                                                                                                                           
 Total stockholders' equity:                          10,629                  11,929                  2,850          
                                                                                                                           
 Total liabilities and stockholders' equity     $     36,082           $      43,128            $     27,066         


 SCIENTIFIC LEARNING CORPORATION                                                                                             
 CONDENSED STATEMENTS OF OPERATIONS                                                                                          
 (In thousands, except per share amounts)                                                                                    
 Unaudited                                                                                                                   
                                                                                                                         
                                                                  Three months ended March 31,                             
                                                                         2010                         2009           
                                                                                                                         
 Revenues:                                                                                                               
 Products                                                         $      5,502                 $      3,971          
 Service and support                                                     5,563                        4,653          
 Total revenues                                                          11,065                       8,624          
                                                                                                                         
 Cost of revenues:                                                                                                       
 Cost of products                                                        519                          401            
 Cost of service and support                                             2,434                        2,196          
 Total cost of revenues                                                  2,953                        2,597          
                                                                                                                         
 Gross profit                                                            8,112                        6,027          
                                                                                                                         
 Operating expenses:                                                                                                     
 Sales and marketing                                                     5,950                        5,443          
 Research and development                                                1,968                        1,537          
 General and administrative                                              2,063                        1,940          
                                                                                                                         
 Total operating expenses                                                9,981                        8,920          
                                                                                                                         
 Operating loss                                                          (1,869  )                    (2,893  )      
                                                                                                                         
 Interest and other income                                               16                           61             
                                                                                                                         
 Net loss before income tax                                              (1,853  )                    (2,832  )      
 Income tax expense                                                      46                           29             
 Net loss                                                         $      (1,899  )             $      (2,861  )      
                                                                                                                         
 Basic and diluted net loss per share:                            $      (0.10   )             $      (0.16   )      
 Shares used in computing basic and diluted net loss per share           18,338                       17,863         


 SCIENTIFIC LEARNING CORPORATION                                                                                                      
 CONDENSED STATEMENTS OF CASH FLOWS                                                                                                   
 (In thousands)                                                                                                                       
 Unaudited                                                                                                                            
                                                                                                                                  
                                                                          Three months ended March 31,                              
                                                                                 2010                          2009           
                                                                                                                                  
 Operating Activities:                                                                                                            
 Net loss                                                                 $      (1,899   )             $      (2,861  )      
 Items to reconcile net loss to net cash used in operating activities:                                                            
 Depreciation and amortization                                                   622                           359            
 Stock based compensation                                                        479                           408            
 Changes in operating assets and liabilities:                                                                                     
 Accounts receivable                                                             2,972                         2,276          
 Prepaid expenses and other current assets                                       (180     )                    (456    )      
 Other assets                                                                    (21      )                    68             
 Accounts payable                                                                (355     )                    51             
 Accrued liabilities                                                             (3,733   )                    (902    )      
 Deferred revenue                                                                (1,708   )                    (2,679  )      
 Other liabilities                                                               50                            31             
                                                                                                                                  
 Net cash used in operating activities                                           (3,773   )                    (3,705  )      
                                                                                                                                  
 Investing Activities:                                                                                                            
 Purchases of property and equipment, net                                        (642     )                    (297    )      
 Purchases of investments                                                        (8,112   )                    -              
 Additions to capitalized software                                               -                             (325    )      
                                                                                                                                  
 Net cash used in investing activities                                           (8,754   )                    (622    )      
                                                                                                                                  
 Financing Activities:                                                                                                            
 Borrowings under bank line of credit                                            -                             2,500          
 Proceeds from issuance of common stock, net                                     129                           258            
                                                                                                                                  
 Net cash provided by financing activities                                       129                           2,758          
                                                                                                                                  
 Decrease in cash and cash equivalents                                           (12,398  )                    (1,569  )      
                                                                                                                                  
 Cash and cash equivalents at beginning of period                                20,679                        7,550          
                                                                                                                                  
 Cash and cash equivalents at end of period                               $      8,281                  $      5,981          


 Scientific Learning Corporation                                                                                                                            
 Supplemental Information                                                                                                                                   
                                                                                                                                                      
 Reconciliation of Booked Sales, Revenue and Change in Deferred Revenue                                                                                     
                                                                                                                                                      
 $s in thousands                                                                                                                                      
                                                        First Quarter                                                                                   
                                                                    2010                                   2009                                   
                                                                                                                                                      
 Booked Sales                                           $           8,025                       $          6,032                                  
 Less Revenue                                                       (11,065     )                          (8,624     )                           
 Other adjustments                                                  1,331                                  (87        )                           
 Net decrease in current and long-term deferred         $           (1,709      )               $          (2,679     )                           
                                                                                                                                                      
 Beginning balance in current and long-term deferred                22,230                                 19,952                                 
 Ending balance in current and long-term deferred       $           20,522                      $          17,273                                 
                                                                                                                                                      
                                                                                                                                                      
 Booked sales is a non-GAAP financial measure that we believe to be a useful measure of the current level of business activity both for management and for investors. Booked sales equals the total value (net of allowances) of software and services invoiced in the period. Because a significant portion of our revenue is recognized over a period of months, booked sales is a good indicator of current activity. The table above shows the reconciliation of booked sales, revenue, and changes in deferred revenue. 
                                                                                                                                                      
 Reconciliation of Net Income to EBITDAS                                                                                                                    
                                                                                                                                                      
 $s in thousands                                                                                                                                      
                                                        First Quarter                                                                                   
                                                                    2010                                   2009                                   
                                                                                                                                                      
 Net loss                                               $           (1,899      )               $          (2,861     )                           
 Adjustments to reconcile to EBITDAS:                                                                                                                 
 Income tax provision                                               46                                     29                                     
 Interest income, net                                               (11         )                          (4         )                           
 Depreciation and amortization                                      622                                    359                                    
 Stock compensation expense                                         479                                    408                                    
 Adjusted EBITDAS                                       $           (763        )               $          (2,069     )                           
                                                                                                                                                      
 Earnings before interest, taxes, depreciation, amortization and stock compensation expense (EBITDAS) is a non-GAAP financial measure we believe to be a useful measure of the resources available to the company in the current period. We also believe that EBITDAS will be useful in allowing investors to compare our performance with that of other companies. The table above shows a reconciliation of EBITDAS to Net Income, the closest GAAP measure. 
                                                                                                                                                      
                                                                                                                                                      
                                                                                                                                                      
 Non-Cash Charges                                                                                                                                     
                                                                                                                                                      
 $s in thousands                                        First Quarter                                                                                     
                                                                    2010                                                                                 
                                                        Depreciation &                            Stock-based                            Total        
                                                        Amortization                              Compensation                                        
 Included in:                                                                                                                                         
 Cost of Products                                                   261                                    0                              261    
 Cost of Service and Support                                        64                                     39                             103    
 Operating Expenses                                                 297                                    440                            737    
 Total                                                  $           622                         $          479                       $    1,101  
                                                                                                                                                      
 $s in thousands                                        First Quarter                                                                                     
                                                                    2009                                                                                 
                                                        Depreciation & Amortization               Stock-based Compensation               Total        
 Included in:                                                                                                                                         
 Cost of Products                                                   155                                    0                              155    
 Cost of Service and Support                                        28                                     42                             70     
 Operating Expenses                                                 176                                    366                            542    
 Total                                                  $           359                         $          408                       $    767    


Scientific Learning Corporation
Jessica Lindl, 510-625-6784 (Media)
Senior Vice President, Marketing and Product Management
jlindl@scilearn.com
Bob Feller, 510-625-2281 (Investors)
Chief Financial Officer
investorrelations@scilearn.com

Copyright Business Wire 2010

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.